1. Home
  2. Mangaluru, Mumbai to be first Indian cities to submerge: NASA study

Mangaluru, Mumbai to be first Indian cities to submerge: NASA study

News Network
November 18, 2017

Mangaluru, Nov 18: In what will come as a big shock for the residents of both Mumbai and Mangaluru, their beloved cities are in big danger and they should be aware of what is likely to happen, sooner rather than later.

The port city of Karnataka, Mangaluru is currently at risk of flooding from the sea levels. As per the data released by NASA, this is due to melting glaciers. In next 100 years, glacial melting may push sea levels of the city by 15.98cm as compared to 15.26cm for Mumbai and 10.65cm for New York respectively.

The study has been carried out in journal Science Advances. The study is based on findings by the scientists at NASA’S Jet Propulsion Laboratory. The research is based on forecasting tool and gradient fingerprint mapping (GFM). The tool helps planners to find out on how melting glaciers can push up sea levels for nearly 293 major port cities, including Mangaluru, Mumbai in Maharashtra and Kakinada in Andhra, a report said.

The GFM tool shows how troubling the rise of sea-levels is. An ice sheet is a glacier that covers huge area and the melting will release huge amounts of water into the sea, it added.

“By exhaustively mapping these fingerprint gradients, we form a new diagnosis tool, henceforth referred to as gradient fingerprint mapping (GFM), that readily allows for improved assessments of future coastal inundation or emergence,” the study said.

Erik Ivins, senior scientist at the laboratory said that even as cities and countries across the globe plan to weaken flooding, they have to think about next 100 years. As most of the earth’s freshwater is stored in glaciers and ice sheets, their melting owing to global warming is a major reason rising sea level, the paper added.

The melting ice sheets lead to lower gravitational pull on sea waters, permitting them to flow out. The shrinking ice mass results in the swell of the land below. This also impacts the rotation of the earth.

The rise in sea level diminish coasts and can also lead to surges of storm and flooding. Under the high emissions scenario for greenhouse gases, sea level will rise by 0.51 -1.31m by 2100, according to National Oceanic and Atmospheric Administration, as per report.

Comments

PRAMOD BHAT
 - 
Monday, 20 Nov 2017

chances of decreased global warming in near  future is there. Nothing to worry so much

 

Yogesh
 - 
Saturday, 18 Nov 2017

Dont worry.. Jesus walked above sea and the one and only existed god (peace lover religion advocate) will save mangalore.. enjoy..

Huccha
 - 
Saturday, 18 Nov 2017

How it possible...? Mumbai is far away from Tamil Nadu and Kerala.. Those states are placed bottom of map. Mumbai is on top. In between no water and how mumbai alone can go under water.. Rubbish study.. ;-P

Anonymous
 - 
Saturday, 18 Nov 2017

I am proud of that.. NASA studied and mentioned my place also.. Mumbai meri jaan

Unknown
 - 
Saturday, 18 Nov 2017

Wow.. I will get free ices and cold water then.. Waiting for that

Ibrahim
 - 
Saturday, 18 Nov 2017

Everything under control of Allah. Allah will help us.

Kumar
 - 
Saturday, 18 Nov 2017

No worry.. I wont live till that time and I am not married.. 

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 5,2020

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 9,2020

Bengaluru, Feb 9: Senior JD(S) leader and former prime minister H D Deve Gowda has called upon all the regional parties and secular parties to join hands with the Congress and work in tandem to take on the BJP.

Noting that mere speeches would not help, he said the regional and secular parties should enhance their strength politically in the country.

"We all need to join together with Congress and work in tandem with the available strength only then will we be able to stop them (the BJP)," the JD(S) supremo said at a public meeting organised by the party in Hassan district on Saturday.

Gowda cautioned the regional and secular parties against sitting idle watching the developments in the country.

"If the small and regional parties do not exercise the powers given by Dr B R Ambedkar to the country, they (BJP) are going to the extent of finishing them up," he said. Interestingly, the JD(S) patriarch, had in the run-up to the December bypolls to Karnataka assembly said he would not align with the Congress and dubbed it as "not trustworthy."

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.